How to Get GLP-1 Medications Without Insurance: Your Complete Options Guide

Brand-name GLP-1 medications without insurance are genuinely expensive — Ozempic lists at approximately $935 per month, Wegovy at $1,349, Mounjaro at $1,023, and Zepbound at $550–$650 depending on dose. These prices put them out of reach for most people without coverage.

But uninsured patients are not without options. The reality of the GLP-1 market in 2026 is that there are several distinct access pathways — each with different eligibility requirements, timelines, and costs. Understanding them clearly is more useful than a generic directive to "shop around."

This guide covers every realistic option, what each one costs, who qualifies, and what to ask your provider.

Option 1: Compounded Semaglutide or Tirzepatide Through Telehealth

For the majority of uninsured patients seeking GLP-1 medications, compounded versions through cash-pay telehealth providers represent the most accessible and affordable route. Monthly costs range from $99 to $250 depending on dose and provider.

Compounded GLP-1 medications are produced by FDA-registered 503A compounding pharmacies. They contain the same active ingredient — semaglutide or tirzepatide — but are not manufactured by Novo Nordisk or Eli Lilly and do not carry FDA approval as finished drug products. The legal status of compounding has been linked to FDA drug shortage designations, and the regulatory landscape shifts periodically; your telehealth provider should inform you of the current status in your state.

From a clinical standpoint, compounded semaglutide and tirzepatide work through the same receptor mechanism as branded versions. Dose titration follows the same schedule — starting low and increasing gradually over several months. The main practical difference is the delivery format: most compounded versions come as multi-dose vials rather than pre-filled pens, and some patients find self-injection less intuitive with a vial.

What cash-pay telehealth typically includes:

• Provider consultation (usually via video or async messaging)
• Prescription and pharmacy coordination
• Ongoing dose management and check-ins
• Some providers bundle the medication in the monthly cost; others bill separately

Our comparison of no-monthly-fee GLP-1 telehealth providers and our guide to the cheapest compounded semaglutide telehealth options break down current pricing and what to watch for in provider selection.

What to ask a telehealth provider:

1. Is the compounding pharmacy you use FDA-registered (503A or 503B)?
2. Does the monthly price include medication, or is it billed separately?
3. What is the titration schedule, and how is dose adjustment managed?
4. What state-specific requirements apply?

Option 2: Manufacturer Patient Assistance Programs

If you meet the income criteria, manufacturer patient assistance programs (PAPs) can provide brand-name GLP-1 medications at little or no cost. The programs are real — but they are harder to access than the marketing suggests, and they are not designed for uninsured patients seeking GLP-1s primarily for weight loss.

Novo Nordisk (Ozempic, Wegovy, Victoza):

• NovoCare Patient Assistance Program — covers Ozempic for qualifying patients, primarily those with type 2 diabetes. Eligibility typically requires household income at or below 400% of the federal poverty level (~$60,000/year for an individual), no current insurance coverage, and a U.S. prescription. Call 1-833-NOVO4ME or apply at novocare.com.
• Wegovy Savings Card — for insured patients with a commercial plan (not Medicaid/Medicare). Reduces out-of-pocket cost; not applicable to the uninsured.

Eli Lilly (Mounjaro, Zepbound):

• Mounjaro Savings Card — reduces cost for commercially insured patients. Not available to Medicare/Medicaid beneficiaries.
• Zepbound Savings Card — similar structure; reduces Zepbound cost for eligible commercially insured patients.
• Lilly Cares Foundation — covers Mounjaro for uninsured or underinsured patients who meet income thresholds (~$40,000/year individual). Requires provider confirmation of the diabetes diagnosis. Apply at lillycares.com.

Timeline and practical considerations:

PAP applications typically take 2–6 weeks to process. You will need your provider to complete a portion of the application. Approval is not guaranteed, and many applications for weight management (vs. diabetes treatment) are denied.

If you have a diabetes diagnosis and meet income requirements, a PAP is worth pursuing. For weight management without a diabetes diagnosis, the eligibility criteria are significantly narrower.

Option 3: GoodRx and Retail Pharmacy Discounts

GoodRx and similar prescription savings platforms can reduce the retail cost of brand-name GLP-1 medications — but the savings are modest compared to the overall price.

A typical GoodRx coupon for Ozempic 0.5mg (4 pens) at a major retail pharmacy will show prices in the range of $800–$900, compared to the ~$935 list price. Wegovy discounts are similar in relative terms but start from a higher list price.

When GoodRx makes sense:

• You already have a brand-name prescription and need to fill it immediately
• You are transitioning between coverage periods
• You want to compare specific pharmacy prices in your zip code

When GoodRx does not solve the problem:

• You cannot afford $800–$900/month regardless of the discount
• You want to understand all options before committing to a brand-name route

GoodRx cannot be combined with manufacturer savings cards or insurance. It functions as an alternative to insurance, not a supplement.

Option 4: FSA and HSA Accounts

If you have a Flexible Spending Account (FSA) or Health Savings Account (HSA) through an employer, GLP-1 medications may be eligible expenses — but the eligibility depends on the diagnosis.

Semaglutide for type 2 diabetes (Ozempic): Generally FSA/HSA eligible as a treatment for a qualifying medical condition.

Semaglutide or tirzepatide for weight management (Wegovy, Zepbound): FSA/HSA eligibility is less straightforward. As of 2026, the IRS requires that weight-loss treatments be prescribed to treat a diagnosed disease (obesity is classified as a disease under IRS guidance, and the IRS updated this position in 2023 to allow GLP-1s prescribed for obesity to qualify as FSA/HSA eligible expenses). Consult your FSA/HSA administrator and keep your prescription documentation.

Compounded semaglutide: Eligibility varies by plan administrator. Some FSA/HSA plans cover compounded medications prescribed for a diagnosable condition; others do not. Contact your plan administrator before assuming coverage.

The key practical point: if you have pre-tax FSA or HSA dollars available, using them for GLP-1 costs effectively reduces the after-tax price by your marginal tax rate — a 22% federal bracket means a $200/month compounded program actually costs about $156 in real terms.

Option 5: Income-Based Community Health Centers

Federally Qualified Health Centers (FQHCs) operate on a sliding fee scale based on income and serve uninsured patients. While not every FQHC prescribes GLP-1 medications, many do — and a small number have established programs to connect uninsured patients with manufacturer samples, PAPs, or 340B-discounted pricing.

The 340B Drug Pricing Program allows eligible health centers to purchase outpatient drugs at significantly discounted prices. An FQHC participating in the 340B program may be able to dispense Ozempic or Wegovy at a substantially lower cost than retail. Availability varies by facility.

To find an FQHC near you, use the Health Resources & Services Administration (HRSA) locator at findahealthcenter.hrsa.gov. When contacting a center, ask specifically about their GLP-1 medication program and 340B participation.

Option 6: State Pharmaceutical Assistance Programs

A smaller number of states operate their own pharmaceutical assistance programs for residents who meet income criteria. These vary significantly in which medications they cover and at what income thresholds. Key states with relevant programs include New York (EPIC), Pennsylvania (PACE/PACENET), New Jersey (PAAD), and California (which has various county-level programs). These programs are primarily designed for older adults and people with disabilities, but eligibility requirements vary.

Check your state health department's pharmaceutical assistance page for current programs and income cutoffs.

Comparing Your Options at a Glance

What to Ask Your Telehealth Provider Before Starting

If you are approaching a telehealth provider without insurance, the quality of information you get upfront matters. These questions will help you make a clearer comparison:

1. Is the total price quoted per month inclusive of medication, or does medication bill separately? Some providers advertise a low platform fee but charge separately for the medication — your real monthly cost is the sum of both.
2. What compounding pharmacy do you use, and is it 503A or 503B registered? This is a question about quality standards and legal status.
3. How are dose adjustments managed as I titrate up? Some providers charge more for higher doses; others include all doses in a flat monthly rate.
4. What happens if I need to pause treatment or cancel? Subscription terms vary; understanding cancellation policy matters for cash-pay patients.
5. Do you have any PAP navigation support, or can you help me apply for manufacturer assistance? Some providers include this; others do not.

For a side-by-side comparison of providers with transparent cash pricing, see our guide to cheapest compounded semaglutide telehealth.

The cost landscape for GLP-1 medications without insurance is genuinely complex — but navigable. For most patients who do not qualify for manufacturer PAPs, compounded semaglutide via a reputable cash-pay telehealth provider is both the fastest and most affordable path to treatment.